Combination of primary CNS lymphoma and mycobacteriosis of the brain in the background of HIV infection
https://doi.org/10.22328/2077-9828-2023-15-2-106-113
Abstract
Aim of the study. To present a clinical observation of a combined brain tissue lesion in a patient with HIV infection, which emphasizes the complexity of the differential diagnosis process when making a final diagnosis, the need for interdisciplinary interaction of trained specialists.
Materials and methods. The description of clinical observation, results of instrumental diagnostic methods is performed. The data of histological and immunohistochemical examination of the biopsy of the patient’s brain tissue are presented.
Results and conclusion. Damage to the central nervous system in patients with HIV infection is characterized by a wide range of etiological factors. Diagnosis, in this case, is a complex task and requires a comprehensive examination of the patient, including performing computed tomography, magnetic resonance imaging of the brain, as well as cultural and molecular genetic methods of studying cerebrospinal fluid. Pathognomonic clinical manifestations and neuroradiological syndromes do not exist, and several pathogens can be released simultaneously in the biological fluids of the patient. In addition to determining the etiology of the infectious process, it is necessary to exclude a brain tumor lesion with possible biopsy, histological and immunohistochemical verification of the neoplasm.
About the Authors
M. A. SavchenkoRussian Federation
St. Petersburg
N. E. Voinov
Russian Federation
St. Petersburg
D. A. Sitovskaya
Russian Federation
St. Petersburg
O. M. Vorobieva
Russian Federation
St. Petersburg
Yu. M. Zabrodskaya
Russian Federation
St. Petersburg
R. V. Grozov
Russian Federation
St. Petersburg
A. M. Panteleev
Russian Federation
St. Petersburg
References
1. Kolson D. Neurologic Complications in Persons with HIV Infection in the Era of Antiretroviral Therapy // Top Antivir. Med. 2017. Jul./Aug; Vol. 25, No. 3. Р. 97–101. PMID: 28820724; PMCID: PMC5935214.
2. Belyakov N.A., Trofimova T.N., Rassokhin V.V. et al. The interdisciplinary, personalized approach and brain investigation technology in HIV infection. Diagnostic radiology and radiotherapy, 2020, Vol. 11, No. 2, рр. 7–28 (In Russ.). https://doi.org/10.22328/2079-5343-2020-11-2-7-28. EDN VQXISO.
3. Dudina G.A., Mabudzada C.K., Ogannisyan A.A., Nemikin V.N. HIV-associated lymphomas. Creative surgery and oncology, 2022, Vol. 12, No. 4, рр. 320–327 (In Russ.). doi: 10.24060/2076-3093-2022-12-4-320-327. EDN WTQPMM.
4. Lurain K., Uldrick T.S., Ramaswami R. et al. Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate // Blood. 2020. Vol. 136, No. 19. Р. 2229–2232. doi: 10.1182/blood.2020006048.
5. Castelli R., Schiavon R., Preti C., Ferraris L. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy. Cardiovasc. Hematol. Disord Drug Targets. 2020. Vol. 20, No. 3. Р. 175–180. doi: 10.2174/1871529X20666200415121009.
Review
For citations:
Savchenko M.A., Voinov N.E., Sitovskaya D.A., Vorobieva O.M., Zabrodskaya Yu.M., Grozov R.V., Panteleev A.M. Combination of primary CNS lymphoma and mycobacteriosis of the brain in the background of HIV infection. HIV Infection and Immunosuppressive Disorders. 2023;15(2):106-113. (In Russ.) https://doi.org/10.22328/2077-9828-2023-15-2-106-113